๐๐จ๐ฉ๐๐จ๐ง ๐๐ง๐ ๐๐๐ฎ๐ฆ๐๐ญ๐ซ๐ ๐๐จ๐ข๐ง ๐ ๐จ๐ซ๐๐๐ฌ ๐ญ๐จ ๐๐๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ข๐ณ๐ ๐๐ฒ๐...
๐คฏ ๐๐จ๐ฉ๐๐จ๐ง ๐๐๐ค๐ข๐ง๐ ๐๐จ๐ฏ๐๐ฌ ๐คฏ
๐ ๐๐๐ญ๐จ๐ฌ๐ ๐๐ง๐ง๐จ๐ฎ๐ง๐๐๐ฌ ๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐ ๐๐๐ซ๐ญ๐ง๐๐ซ๐ฌ๐ก๐ข๐ฉ ๐ฐ๐ข๐ญ๐ก ๐๐จ๐ฉ๐๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐
datosX Digital Health Labs has entered a strategic partnership and received initial investment from Topcon Healthcare. Backed by THINC Ventures, Topconโs innovation fund, the collaboration will accelerate the development and real-world validation of impactful digital health technologies.
Combining Topconโs global expertise with datosXโs agile validation model, the partnership aims to fast-track market access and improve outcomes for patients and providers. This marks a major step forward in advancing scalable, evidence-based digital health innovation.
๐ ๐๐จ๐ฉ๐๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐๐ช๐ฎ๐ข๐ซ๐๐ฌ ๐๐๐ญ๐๐ง๐๐ข๐ ๐ก๐ญ ๐ญ๐จ ๐๐๐ฏ๐๐ง๐๐ ๐๐-๐๐ซ๐ข๐ฏ๐๐ง ๐๐ฒ๐ ๐๐๐ซ๐
Topcon Healthcare has acquired RetInSight, a Vienna-based leader in AI-powered retinal imaging.
This strategic acquisition strengthens their commitment to making intelligent eye care more accessible, cost-effective, and impactful. RetInSightโs cutting-edge AI algorithms analyse OCT images to detect and monitor leading causes of vision lossโincluding geographic atrophy, neovascular AMD, diabetic macular edema, and retinal vein occlusion. By integrating RetInSightโs technology, theyโre accelerating the delivery of high-quality, AI-driven diagnostics that improve clinical outcomes and expand access to sight-saving care worldwide.
๐ ๐๐จ๐ฉ๐๐จ๐ง, ๐๐จ๐จ๐ซ๐๐ข๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐๐๐ ๐๐๐ฎ๐ง๐๐ก ๐๐๐ฌ๐๐๐๐๐ซ ๐ญ๐จ ๐๐ซ๐ข๐ฏ๐ ๐๐ ๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐๐ฒ๐ ๐๐๐ซ๐
Topcon Healthcare has joined forces with Moorfields Eye Hospital, London and the UCL Institute of Ophthalmology to launch Cascader, a new medtech company focused on accelerating AI-driven diagnostics in ophthalmology.
Cascader will develop tools to detect and manage major eye diseases like AMD, using insights from projects like RETFound and data from the INSIGHT Health Data Research Hubโthe worldโs largest ophthalmic imaging bioresource. This collaboration aims to bring cutting-edge AI from lab to clinic, improving early diagnosis and outcomes across global eye care.